Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMDW) Total Liabilities (2023 - 2025)

Baird Medical Investment Holdings' quarterly Total Liabilities came in at $38.5 million in Q4 2025, up 0.72% year-on-year from $38.2 million in Q4 2024, and down 6.98% quarter-over-quarter from $41.4 million in Q2 2025.

Baird Medical Investment Holdings has reported Total Liabilities for 3 years, with the latest figure at $38.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities rose 0.72% year-over-year to $38.5 million; the trailing twelve-month figure through Dec 2025 stood at $38.5 million (up 0.72% YoY), and the FY2025 full-year result was $38.5 million, up 0.72% from the prior year.
  • Total Liabilities for Q4 2025 stood at $38.5 million, down from $41.4 million in the prior quarter.
  • The five-year high for Total Liabilities was $41.4 million in Q2 2025, with the low at $21.0 million in Q4 2023.
  • Average Total Liabilities over 3 years is $34.8 million, with a median of $38.3 million recorded in 2024.
  • Year-over-year, Total Liabilities surged 81.91% in 2024 and climbed 0.72% in 2025.
  • Tracing BDMDW's Total Liabilities over 3 years: stood at $21.0 million in 2023, then soared by 81.91% to $38.2 million in 2024, then gained by 0.72% to $38.5 million in 2025.
  • The last three Total Liabilities figures came in at $38.5 million (Q4 2025), $41.4 million (Q2 2025), and $38.2 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 57.73 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 23.31 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.29 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 18.25 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 2.99 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 18.55 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 3.68 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 26.23 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 3.54 Bn
10 Baird Medical Investment Holdings - - - 38.48 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 38.48 Mn
Jun 30, 2025 41.37 Mn
Dec 31, 2024 38.20 Mn
Dec 31, 2023 21.00 Mn